(Q36077352)

12 August 2017

1 reference

title

Indirect bronchial hyper-responsiveness: the coming of age of a specific group of bronchial challenges. (English)

1 reference

12 August 2017

Van Schoor J

1

1 reference

12 August 2017

Pauwels R

series ordinal

2

1 reference

12 August 2017

Joos G

series ordinal

3

1 reference

12 August 2017

language of work or name

1 reference

1 March 2005

1 reference

Clinical & Experimental Allergy

12 August 2017

published in

1 reference

12 August 2017

volume

35

1 reference

12 August 2017

issue

3

1 reference

12 August 2017

page(s)

250-261

1 reference

Airway hyperresponsiveness: using bronchial challenge tests in research and management of asthma

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Indirect bronchial hyperresponsiveness in asthma: mechanisms, pharmacology and implications for clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Role of cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

The NK-2 receptor antagonist SR 48968C does not improve adenosine hyperresponsiveness and airway obstruction in allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Inhibitory effect of a leukotriene receptor antagonist (montelukast) on neurokinin A-induced bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Effect of inhaled fluticasone on bronchial responsiveness to neurokinin A in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Airways hyper-responsiveness to bradykinin and methacholine: effects of inhaled fluticasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Efficacy and duration of action of the antileukotriene zafirlukast on cold air-induced bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Release of inflammatory mediators from eosinophils following a hyperosmolar stimulus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Evidence of mast cell activation and leukotriene release after mannitol inhalation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Relationship between airway hyperresponsiveness to mannitol and adenosine monophosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Effects of mediator antagonism on mannitol and adenosine monophosphate challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

A3 adenosine receptor signaling contributes to airway inflammation and mucus production in adenosine deaminase-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Inhibition of human mast cell activation with the novel selective adenosine A(2B) receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)(2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Adenosine-activated mast cells induce IgE synthesis by B lymphocytes: an A2B-mediated process involving Th2 cytokines IL-4 and IL-13 with implications for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

A(2B) adenosine receptors increase cytokine release by bronchial smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Adenosine A3 receptor expression and function in eosinophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Adenosine A3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Pro-inflammatory effects of substance P: new perspectives for the treatment of airway diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

The effect of the NK2 tachykinin receptor antagonist SR 48968 (saredutant) on neurokinin A-induced bronchoconstriction in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Dual tachykinin NK1/NK2 antagonist DNK333 inhibits neurokinin A-induced bronchoconstriction in asthma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

The relationship between airway hyper-responsiveness, markers of inflammation and lung function depends on the duration of the asthmatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Provocation with adenosine 5'-monophosphate as a marker of inflammation in asthma, allergic rhinitis and chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

PC(20) adenosine 5'-monophosphate is more closely associated with airway inflammation in asthma than PC(20) methacholine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Bronchial responsiveness to adenosine 5'-monophosphate (AMP) and methacholine differ in their relationship with airway allergy and baseline FEV(1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Effect of inhaled ciclesonide on airway responsiveness to inhaled AMP, the composition of induced sputum and exhaled nitric oxide in patients with mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Mast-cell infiltration of airway smooth muscle in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5'-monophosphate in mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Changes in sputum counts and airway hyperresponsiveness after budesonide: monitoring anti-inflammatory response on the basis of surrogate markers of airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

The effect of inhaled budesonide on symptoms, lung function, and cold air and methacholine responsiveness in 2- to 5-year-old asthmatic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Sustained reduction in bronchial hyperresponsiveness with inhaled fluticasone propionate within three days in mild asthma: time course after onset and cessation of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Airway wall remodelling: does it occur and what does it mean?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Initial improvements in lung function and bronchial hyperresponsiveness are maintained during 5 years of treatment with inhaled beclomethasone dipropionate and terbutaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Effect of inhaled budesonide on bronchial hyperresponsiveness in adolescents with clinical remission of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Remission of childhood asthma after long-term treatment with an inhaled corticosteroid (budesonide): can it be achieved? Dutch CNSLD Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

How best to measure airway responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Adenosine provocation: a new test for allergic type airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

British Thoracic Society guidelines on respiratory aspects of fitness for diving

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

The asthmatic athlete, inhaled beta agonists, and performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Exercise in elite summer athletes: Challenges for diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Provocation by eucapnic voluntary hyperpnoea to identify exercise induced bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Mannitol as a challenge test to identify exercise-induced bronchoconstriction in elite athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Use of aerosols for bronchial provocation testing in the laboratory: where we have been and where we are going

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

Induction of human B2 bradykinin receptor mRNA and membrane receptors by IFNγ

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

DNA antisense therapy for asthma in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02177.X

10.1111/J.1365-2222.2005.02177.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference